| Term 
 
        | Generic Name for Oral Contraceptives |  | Definition 
 
        | Ovcon 35 Neucon 1/35
 Ortho-novum
 |  | 
        |  | 
        
        | Term 
 
        | Action of Oral Contraceptives |  | Definition 
 
        | Decrease fertility by: - inhibiting ovulation
 -thickening cervical mucus
 -making lining of endometrieum less favorable for implantation
 |  | 
        |  | 
        
        | Term 
 
        | Side effects of Oral Contraceptives (Ovcon, Necon 1/35, ortho-novum
 |  | Definition 
 
        | 1. HTN 2. Breakthrough bleeding
 3. Thromboembolic events (MI, PE--> STOP SMOKING)
 4. Cervical Cancer (HPV risk; papsmear)
 |  | 
        |  | 
        
        | Term 
 
        | Drugs that decrease the effectiveness of oral contraceptives |  | Definition 
 
        | -ampicillin -tetracycline
 -carbamazepine
 -phenobarbital
 -phenytoin
 |  | 
        |  | 
        
        | Term 
 
        | Oral contraceptives decrease the effectiveness of which drugs? |  | Definition 
 
        | Oral hypoglycemics Warfarin
 |  | 
        |  | 
        
        | Term 
 
        | What should you encourage to patients taking oral contraceptives? |  | Definition 
 
        | -take pill same time each day -STOP smoking
 |  | 
        |  | 
        
        | Term 
 
        | Generic name for progesterones |  | Definition 
 
        | medroxyprogesterone acetate (Provera) norethindrone (Micronor)
 megestrol acetate (Megace)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -induces favorable environment for: - fetal growth & development
 -maintain pregnancy
 |  | 
        |  | 
        
        | Term 
 
        | Drop in progesterone levels results in _____ |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -counters adverse effects of estrogen in HRT: 1. dysfunctional uterine bleeding
 2. Amenorrhea d/t hormonal imbalance
 3. Endometriosis
 4. Endometrial carcinoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. Breast cancer (AVOID administration) 2. Thromboembolic events
 3. Breakthrough bleeding
 4. Edema
 |  | 
        |  | 
        
        | Term 
 
        | Crabamazepine Phenobarbital
 phenytoin
 rifampin
 |  | Definition 
 
        | contraceptive effectiveness decrease with the use of these drugs |  | 
        |  | 
        
        | Term 
 
        | Client Teaching for Progesterone |  | Definition 
 
        | -anticipate withdrawal bleeding 3-7 days after stopping medications |  | 
        |  | 
        
        | Term 
 
        | Evidence of progesterone effectiveness: |  | Definition 
 
        | -restoration of hormonal balance with control of uterine bleeding -restoration of menses
 -decrease in endometrial hyperplasia in postmenopausal women receiving estrogen
 -controls spread of endometrial cancer
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | conjugated equine estrogens (Premarin) Estradiol
 |  | 
        |  | 
        
        | Term 
 
        | What is estrogen needed for? |  | Definition 
 
        | -female growth/reproduction & traits -block bone resorption
 -decrease LDL
 -suppress FSH (FSH needed for conception)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -contraception -post menopause
 -osteoporosis
 -prostate cancer
 -uterine bleeding/endometriosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. Endometrial/ovarian cancer --> give with progesterone; biopsy q2 years
 2. Risk of estrogen dependent breast CA
 --> self breast exams
 3. Embolic events
 4, Males = gyncocomastia, impotence, penile atophy
 |  | 
        |  | 
        
        | Term 
 
        | Interaction of estrogen and warfarin |  | Definition 
 
        | 1. Estrogen decreases warfarin effectiveness --> may need to INCREASE warfarin levels
 |  | 
        |  | 
        
        | Term 
 
        | T/F Phenytoin increases estrogen toxicity |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -required for growth and maturation of male sex organs -promotes skeletal muscle growth (anabolic steroid effect) in sexually mature males
 |  | 
        |  | 
        
        | Term 
 
        | Uses for testosterone -fluoxymesterone (Halostestin)
 -danazol (Danocine)
 |  | Definition 
 
        | -hypogonadism -delayed puberty
 -pallative tx for breast cancer
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. CV (increase LDL, decrease HDL, edema) 2. Hepatoxcity
 3. Hypercalcemia (breast -ca)
 4. Virilism effects: acne
 -M= gyncomastia, impotence, priapism, acne
 -F= deeper voice, hirtuism, menstraul irregulatiries
 |  | 
        |  | 
        
        | Term 
 
        | Testosterone and effects with: Warfarin
 Glucocorticoids
 Oral Hypoglycemics
 |  | Definition 
 
        | increases effects: monitor for -bleeding, anemia
 -infection
 -hypOglycemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. oxytocin 2. methylergonaovine
 |  | 
        |  | 
        
        | Term 
 
        | Action of uterine stimulants (oxytocin, methyergonovine)
 |  | Definition 
 
        | increase strength, frequency, length of uterine contraction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -induction of labor -control of post partum bleeding
 -fetal stress testing
 -Intranasal = promotion of milk let down)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -emergency intervention for serious postpartum hemorrhage |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | uterine rupture -> magnesium sulfate on standby for relaxation of myometrium
 |  | 
        |  | 
        
        | Term 
 
        | s/e of methylergonovine (Methergine) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What medication should you avoid with uterine stimulatns (oxytocin) |  | Definition 
 
        | vasopressors. WHY? - can lead to HTN
 |  | 
        |  | 
        
        | Term 
 
        | How should uterine stimulants (oxytocin) be administered? |  | Definition 
 
        | infusion pump -gradually increase flow rate by 1mu/min q 30 min
 |  | 
        |  | 
        
        | Term 
 
        | What should you monitor with the administration of oxytocin? |  | Definition 
 
        | -fetal HR -uterine hyperstimulation
 (contractions longer than 60 sec
 occurring q 2-3 minutes)
 
 STOP INFUSION
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -terbutaline sulfate (Brethine) -magnesium sulfate
 -ritodrine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | selectively activates beta 2-adrenergic receptors (beta 2 adrenergic agonist) RESULTING in -utereine smooth muscle relaxation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | delay preterm labor can be used up to 48 hrs
 via IV/SC
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | delay preterm labor can be used up to 48 hrs
 via IV/SC
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -tachycardia -palpitations
 -chest pain
 -tremors
 -anxiety
 -ha
 |  | 
        |  | 
        
        | Term 
 
        | What interaction does terbutaline have with androgen agonist/ |  | Definition 
 
        | -can cause concurrent additive effects -monitor for tachycardia, tremors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | can cause HTN (monitor for HTN crisis)
 |  | 
        |  | 
        
        | Term 
 
        | Beta blockers and androgen |  | Definition 
 
        | -monitor for negation of effects |  | 
        |  |